
Home / About
All categories
Development History

2010年 奥翔药业成立,厂房开工建设

2012年 公司第一个车间开始投产

2014年 与郑州大学签约治疗脑卒中一类新药BZP技术转让

2016 Passed PMDA audit

2017 Successfully listed on the Shanghai Stock Exchange

2020 The company was audited by Russia
In 2010
- Founded in April 2010
- the Company founded the first academician expert workstation in Taizhou City
In 2012
- The company's first workshop began production
In 2014
- the Company was rated as a High-tech Enterprise
- Passed US FDA audit.
- First certification of ISO14001 standard
- First occupational health and safety standard 18001
- Contract with Zhengzhou University on technology transfer of BZP, a new drug for the treatment of stroke
- The company has set up Zhejiang academician expert workstation and high-tech enterprise research and development center
- The company passed the EU GMP audit and obtained the certificate
In 2015
- The company applied to go public
- The company has set up a post-doctoral workstation and a provincial enterprise research institute
In 2016
- The company passed PMDA audit
In 2017
- The company is listed on the Shanghai Stock Exchange
In 2018
- The company passed FDA audit again
In 2019
- The company passed the Chinese GMP audit
In 2020
- The company was audited by Russia
In 2021
- First certification of intellectual property management system
In 2022
- Recognized as a provincial-level key research institute, national level intellectual property advantage enterprise, and Zhejiang Province intellectual property demonstration enterprise
Copyright © Zhejiang Ausun Pharmaceutical Co., Ltd. 浙ICP备09045528号 Power:300.cn
- Sales division 0576-85589335
- Administration office 0576-85589367
- Top